Breast Cancer Treatment: Overcoming Resistance with New Combination Therapy

Discover a groundbreaking approach to treating hormone-resistant, estrogen receptor-positive (ER+) breast cancer. Researchers at Sylvester Comprehensive Cancer Center have developed a new combination therapy that targets the cellular 'bodyguards' in breast cancer cells, leading to tumor shrinkage and improved survival rates. Learn more about this innovative treatment and its potential impact on breast cancer management.